Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuti

Showing results (211-220 of 596) with videos related to

Pageof 60
Sort By:
International Journal of Antimicrobial Agents|October 19, 2006
Optimising antibiotic dosing regimens based on pharmacodynamic target attainment against Pseudomonas aeruginosa collected in Hungarian hospitalsEndre Ludwig, Marianne Konkoly-Thege, Joseph L Kuti, et al.
Singapore Medical Journal|April 30, 2010
Oral misoprostol versus intramuscular oxytocin in the active management of the third stage of labourE O Afolabi, O Kuti, E O Orji, et al.
Pharmacotherapy|October 30, 2007
Optimal dosing of piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa infections: prolonged or continuous infusion?Aryun Kim, Christina A Sutherland, Joseph L Kuti, et al.
The Journal of Infection|October 19, 2005
Clinical implications of extended spectrum beta-lactamase (ESBL) producing Klebsiella species and Escherichia coli on cefepime effectivenessSrividya Kotapati, Joseph L Kuti, Charles H Nightingale, et al.
The Journal of Antimicrobial Chemotherapy|May 28, 2013
In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumanniiSeth T Housman, Mao Hagihara, David P Nicolau, et al.
Antimicrobial Agents and Chemotherapy|November 27, 2013
In vitro pharmacodynamics of polymyxin B and tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumanniiMao Hagihara, Seth T Housman, David P Nicolau, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 23, 2014
Stability of ertapenem 100 mg/mL in polypropylene syringes stored at 25, 4, and -20 °CJami G Jain, Christina Sutherland, David P Nicolau, et al.
Infectious Diseases and Therapy|June 30, 2019
Evaluation of Plazomicin, Tigecycline, and Meropenem Pharmacodynamic Exposure against Carbapenem-Resistant Enterobacteriaceae in Patients with Bloodstream Infection or Hospital-Acquired/Ventilator-Associated Pneumonia from the CARE Study (ACHN-490-007)Joseph L Kuti, Aryun Kim, Daniel J Cloutier, et al.
Clinical Therapeutics|May 4, 2010
Pharmacodynamic modeling of intravenous antibiotics against gram-negative bacteria collected in the United StatesPornpan Koomanachai, Catharine C Bulik, Joseph L Kuti, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|November 18, 2003
A comparative study between intramuscular iron dextran and oral ferrous sulphate in the treatment of iron deficiency anaemia in pregnancyJ O Komolafe, O Kuti, K T Ijadunola, et al.
Pageof 60

Showing results (211-220 of 596) with videos related to

Sort By:
Pageof 60
International Journal of Antimicrobial Agents|October 19, 2006
Optimising antibiotic dosing regimens based on pharmacodynamic target attainment against Pseudomonas aeruginosa collected in Hungarian hospitalsEndre Ludwig, Marianne Konkoly-Thege, Joseph L Kuti, et al.
Singapore Medical Journal|April 30, 2010
Oral misoprostol versus intramuscular oxytocin in the active management of the third stage of labourE O Afolabi, O Kuti, E O Orji, et al.
Pharmacotherapy|October 30, 2007
Optimal dosing of piperacillin-tazobactam for the treatment of Pseudomonas aeruginosa infections: prolonged or continuous infusion?Aryun Kim, Christina A Sutherland, Joseph L Kuti, et al.
The Journal of Infection|October 19, 2005
Clinical implications of extended spectrum beta-lactamase (ESBL) producing Klebsiella species and Escherichia coli on cefepime effectivenessSrividya Kotapati, Joseph L Kuti, Charles H Nightingale, et al.
The Journal of Antimicrobial Chemotherapy|May 28, 2013
In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumanniiSeth T Housman, Mao Hagihara, David P Nicolau, et al.
Antimicrobial Agents and Chemotherapy|November 27, 2013
In vitro pharmacodynamics of polymyxin B and tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumanniiMao Hagihara, Seth T Housman, David P Nicolau, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|August 23, 2014
Stability of ertapenem 100 mg/mL in polypropylene syringes stored at 25, 4, and -20 °CJami G Jain, Christina Sutherland, David P Nicolau, et al.
Infectious Diseases and Therapy|June 30, 2019
Evaluation of Plazomicin, Tigecycline, and Meropenem Pharmacodynamic Exposure against Carbapenem-Resistant Enterobacteriaceae in Patients with Bloodstream Infection or Hospital-Acquired/Ventilator-Associated Pneumonia from the CARE Study (ACHN-490-007)Joseph L Kuti, Aryun Kim, Daniel J Cloutier, et al.
Clinical Therapeutics|May 4, 2010
Pharmacodynamic modeling of intravenous antibiotics against gram-negative bacteria collected in the United StatesPornpan Koomanachai, Catharine C Bulik, Joseph L Kuti, et al.
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|November 18, 2003
A comparative study between intramuscular iron dextran and oral ferrous sulphate in the treatment of iron deficiency anaemia in pregnancyJ O Komolafe, O Kuti, K T Ijadunola, et al.
Pageof 60